Introduction
Cell reproduction, which is fundamental to all life, occurs through an elaborate series of events known as the "cell cycle," where genomic DNA and other cellular components are duplicated and then distributed into two daughter cells. 1, 2 In eukaryotic cells, cyclins and cyclin-dependent protein kinases (Cdks) are master regulators of the cell cycle. 1, 2 During the eukaryotic cell cycle, the volume of the nucleus almost doubles, but the mechanism for this growth during the cell cycle is poorly understood, particularly in mammalian cells. 1 The number of nuclear pore complexes (NPCs), the channels for macromolecular transport between the cytoplasm and nucleus, also doubles as the cell cycle progresses. [3] [4] [5] [6] [7] NPCs are supramolecular complexes, assembled from multiple copies of approximately 30 different proteins, termed nucleoporins (Nups). For the "economical" formation of NPCs during cell proliferation, their expression and formation process needs to be highly controlled. There must be a "global regulation" of interphase NPC formation coupled strictly with the cell cycle, to avoid a huge waste of energy.
Structural aspects of nuclei and NPCs have been characterized in detail. However, their formation and regulation, especially during interphase with a closed nuclear envelope, remained unclear. [3] [4] [5] [6] [7] To address this question, we established novel techniques to study nuclear volume and NPC formation, and investigated how they were regulated during interphase in dividing human cells. 8, 9 Our results indicate that Cdks, especially Cdk1 and Cdk2, control NPC formation during interphase. 9 Cdk inhibition suppressed the generation of the "nascent pores," which are immature NPCs in the process of forming and interrupted expression and localization of some nucleoporins. Surprisingly, we also demonstrated that Cdk inhibition did 10 When we used Nup62-YFPexpressing cells, the NPC acceptor nuclei acquired Nup62-YFP signals without interphase NPC formation, likely due to the rapid turnover of Nup62-YFP within NPCs (Maeshima K, et al. unpublished) . Additionally, in both systems, the fraction with the Mek1 inhibitor, PD98059, suggesting that the Ras/Erk signaling pathway was involved in this process ( fig. 1) .
The manual counting of NPCs to examine density proved laborious and prone to error, and the low resolution of light microscopy was insufficient to distinguish between adjacent NPCs. Increases in the nuclear surface area with cell cycle progression also affected the NPC density. To overcome these problems, we used two novel approaches to directly visualize newly formed NPCs on nuclear surfaces during interphase ( fig. 2a and B) . In the heterokaryon method, cells expressing Nup133-YFP or YFP-Nup107 were used as NPC donor cells and CFP-histone 2B (H2B)-expressing cells were used as NPC acceptor cells (fig. 2a) . The two cell types were mixed at an appropriate density and polyethylene glycol (PEG) treatment resulted in the formation of heterokaryons ( fig. 2a) . Newly formed NPCs were visualized on the NPC acceptor nuclei in the heterokaryons ( fig. 2a) . In the photobleaching method, selected nuclear surface regions in G 1 -phase cells expressing Nup133-YFP or YFP-Nup107 were photobleached using a 488 nm laser. After not effect nuclear growth, revealing that nuclear growth and NPC formation have distinct regulation in the cell cycle. 
Novel Approaches for Investigating Nuclear Growth and NPC Formation during Interphase
To measure nuclear volume and NPC density throughout the cell cycle, synchronized HeLa cells were viewed as three-dimensional image stacks under a fluorescence microscope after nuclear and NPC staining. Nuclear volume was measured using newly developed image processing software for the segmentation and extraction of nuclear area from the image stacks. NPC density was measured using manual counting. Both nuclear volume and NPC density gradually increased during cell cycle progression ( fig. 1 ), but the changes did not follow the same pattern. new NPC formation during interphase ( fig. 3 ) since Pom121 may be the seed for interphase NPC formation ( fig. 3) .
Scanning electron microscopy (SEM) of the freeze-fractured nuclear surfaces identified small NPCs, "the nascent pores" ( fig. 3 ) in the G 1 /S phase of HeLa cells, but not in roscovitine-treated cells. 9 Recently, using baby hamster kidney tsBN2 cells, a temperature-sensitive mutant of RCC1, we established a system allowing the inhibition or initiation of interphase NPC formation by changing the temperature. 8 In this system, interphase NPC formation actively occurs at permissive temperature (32°C), but not at non-permissive temperature (39.7°C) cells. 9 Nups 62, 88, 93, 98, 107 and 133 were expressed at similar levels in roscovitine-treated and control cells. Nups 62, 107 and 133 were co-localized in the cytoplasm, forming large dots or foci on Cdk inhibition. Elys/Mel28, Pom121, Nup153 and RanBP2 expression was reduced by 30-40% in roscovitine-treated cells compared with control cells. 9 Several groups recently reported the importance of Pom121 for the recruitment of the Nup107-160 complex into new assembly sites of NPC on closed nuclear envelopes. [11] [12] [13] These observations agree closely with live-cell imaging of NPC formation. 14 Downregulation of Pom121 by Cdkinhibition could be a reason to suppress of Nup107 or Nup133 that was fluorescently labeled and how much excess YFPNup107 or Nup133-YFP was expressed are also critical issues, because they have important implications in the interpretation of the data. When the expression levels of exogenous and endogenous Nups were examined, we observed that endogenous proteins were dramatically downregulated, possibly to maintain a constant level of Nup107 or Nup133 protein (Sup. Fig. 4 in ref. 9) . Using Nup62 as a normalization control, the total signal intensity of YFP-Nup107 and endogenous Nup107 in the stable cell line was similar to the signal intensity of endogenous Nup107 in the control cells (0.9823). The corresponding ratio for Nup133 was 1.853, indicating slight overproduction. In the stable cell lines, 62.9% of Nup107 proteins and 84.6% of Nup133 proteins were labeled fluorescently. The amount of endogenous Nup62 was also markedly reduced in cells stably expressing Nup62-YFP (Maeshima K, et al. unpublished). These results suggest that ectopic Nup expression is unlikely to be problematic in our systems, and that the cellular system maintains Nups at constant levels. The existence of such a Nup monitoring system is an intriguing topic for further investigation.
Possible Mechanisms for Cdk-Mediated Control of NPC Formation during Interphase
We found that Cdk inhibition almost entirely blocked interphase NPC formation ( fig. 1) (C) in the tsBN2 cell, which is a temperature-sensitive mutant of rCC1 that is a guanine nucleotide exchange factor for ran, a loss of rCC1 inhibits NPC formation during interphase. this allows the inhibition or initiation of NPC formation by changes in temperature. in this system, interphase NPC formation actively occurs at permissive temperature (32°C), but not at non-permissive temperature (39.7°C).
cells. 9 Second, inhibition of Cdk9 activity by flavopridol, which is currently thought to mainly target Cdk9, 19 leads to dramatic suppression of global mRNA production; 20 this is not observed with roscovitine. 21 Thus, from our study, we conclude that Cdk1 and Cdk2 are the most likely major targets of roscovitine and purvalanol A.
Distinct Assembly Mechanisms between Post-Mitotic NPC Assembly and Interphase NPC Formation
In the metazoan cell cycle, there are two periods of NPC formation: post-mitotic NPC assembly and interphase NPC formation. [3] [4] [5] [6] [7] Post-mitotic NPC assembly occurs concomitantly with the formation of NEs around chromatin. 22 It begins in early anaphase, 14, 23 with the recruitment of the Nup107-160 scaffold complex to the chromatin. The recruitment is mediated by Elys/Mel28. [24] [25] [26] During interphase, the number of NPCs on the nuclear surface doubles in preparation for re-entry into mitosis. 27 Much less was known about the mechanism of interphase NPC formation than about postmitotic processes. [4] [5] [6] [7] Although we showed that Cdk activity was essential for interphase NPC formation, Cdk activity was not required for post-mitotic NPC assembly, demonstrating that post-mitotic NPC assembly and interphase NPC formation are differentially regulated. 9 Consistent with this finding, other groups recently determined distinct aspects of postmitotic NPC assembly and interphase NPC formation. Hetzer's group demonstrated that Elys/Mel28 is required for post-mitotic NPC assembly, but not during interphase. 11 Ellenberg's group also showed that interphase NPC formation is initiated by slow accumulation of Pom121 followed by more rapid association of the soluble NPC subcomplex Nup107-160. 14 In the case of postmitotic NPC assembly, an inverse order of recruitment from Nup107-160 to Pom121 occurs.
14 These findings indicate distinct molecular mechanisms between post-mitotic NPC assembly and interphase NPC formation. inhibit the kinase activity by competing with ATP at the ATP binding site of the kinase. 16, 17 Reported in vitro targets of roscovitine are Cdks 1, 2, 5, 7 and 9 (IC 50 < 1 μM). 16 A further Cdk inhibitor, purvalanol A, also used in our study, is similar to roscovitine in its selectivity.
17 Cdk1 (and also Cdk2) are major cell cycle drivers in mammalian cells, whereas Cdk5 has neuron-specific expression and function. 1, 18 Cdk7 functions as a Cdk-activating kinase and is essential for activity of the transcription factor TFIIH. 1, 18 Cdk9 is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. 1, 18 In addition to the involvement of Cdk1 and Cdk2 in interphase NPC formation, 9 does Cdk7 or Cdk9 have an effect on interphase NPC formation? We cannot exclude this possibility, but we think it is unlikely that the suppression of general transcription through Cdk7 and Cdk9 inhibition would have major effects on NPC formation, for the following reasons. First, neither roscovitine nor purvalanol A affects nuclear growth during interphase. 9 Expression levels of all inner nuclear membrane proteins examined were similar between roscovitine-treated and control ( fig. 2c ) although detailed mechanism of the inhibition remains unclear. Again, we only found nascent pores in tsBN2 cells when new NPC formation was active during interphase (sup. fig. 7 in ref. 9 ). These findings indicate that the nascent pores are not species-or cell-type-specific and suggest they could be immature pores under construction. The nascent pores we observed were evenly distributed and not paired or clustered (Maeshima K, et al. unpublished) , indicating that they were not generated by splitting of preexisting NPCs. Because we assume that the nascent pores are a rate-limiting step of immature pores under construction, a structural analysis of the nascent pores may provide new clues to NPC formation.
How Can Cdk Inhibitors Work in Cells?
To examine the global regulation of interphase NPC formation, we used smallmolecule inhibitors, which are widely used to examine protein function (reviewed in ref. 15 ). An advantage of such inhibitors is they act rapidly to inactivate function, whereas small-interfering RNA (siRNA) do not affect function for 48-72 h or longer after transfection. Here, we discuss the possible in vivo target(s) of roscovitine and purvalanol A, both of which 
NPC Formation, Nuclear Growth and Tumor Cells
In our previous study, we showed that the NPC density of quiescent G 0 nuclei in normal human fibroblasts was similar to that of G 1 nuclei. 28 However, the NPC density in replicative senescent cells was much higher, even though both the quiescent and senescent cells were in a nondividing state. 28 This is not so surprising because the proliferation signaling (Ras/ Erk) activates Cdks.
1 Indeed, the Mek1 inhibitor, PD98059, blocked NPC formation during interphase ( fig. 1) (Maeshima  K, et al. unpublished result) . In G 0 cells, Ras/Erk signaling is inactivated, and the NPC density may remain low, as in G 1 nuclei. In contrast, the activation of Ras/Erk signaling by oncogenic Ras was reported to induce senescence of human fibroblasts, 29 suggesting that activation of Ras/Erk signaling increased NPC density in the senescent cells.
Similarly, in normal human fibroblasts, G 0 cells induced by serum depletion have smaller nuclei 9 than senescent cells. 30 The large nuclei in senescent cells may be due to the activation of Ras/Erk signaling by oncogenic Ras. This theory is in good agreement with the finding that inhibition of Mek1, but not of Cdks, blocked nuclear growth during interphase. 9 These results suggest a general relationship between nuclear size and Ras/Erk signaling. Interestingly, when Cdk activity was suppressed in our study, the nuclei were larger than in the control cells. However, this can be explained by roscovitine transiently stimulating the Ras/Erk pathway, 21 again showing a close link of nuclear size and Ras/Erk signaling.
Two groups using budding and fission yeasts reported that yeast nuclei undergo a continuous increase in volume, independent of the cell cycle. 31, 32 Thus, our finding that nuclear growth does not depend on Cdk activity and is independent of the cellular DNA content may be universal in eukaryotes. The Ras/Erk pathway is not well conserved in the budding yeast; in fission yeast, there are three pathways (Ras1-Spk1/Pmk1-MAPK/Sty1/Spc1/ Phh1-SAPK), which are equivalent or related to Ras/Erk signaling in mammalian cells. [33] [34] [35] It is intriguing to investigate
